Tag Archives: CYAD

Top Biotech Stocks To Invest In 2019

Introduction

Roche ADRs (OTCQX:RHHBY) remain in a downtrend even as the company has increased its guidance, following detailed but interim Q1 results (no EPS reported), to modest organic growth this year, but high-single-digit growth including the effects of last December’s US tax legislation. Coming into the important ASCO (oncology) meeting this weekend, this article provides an update on this mega-cap in view of the conflict between several pieces of positive news flow and the steady move down in the stock.

RHHBY is both the world’s largest biotech company and the world’s largest diagnostics company. The current yield is 4.0%; I expect about a 5% increase in the dividend next year, so I am looking at this security as carrying a forward yield of 4.2%. RHHBY could cut a good deal from R&D and would still be spending a higher proportion of pharma revenues on R&D than Merck (MRK) or Pfizer (PFE). So why does the stock chart look like this, relative to the S&P 500 (SPY) – of which it is not a member, being a Swiss company – or a pharma stock index (DRG)?

Top Biotech Stocks To Invest In 2019: JetPay Corporation(JTPY)

Advisors’ Opinion:

  • [By Joseph Griffin]

    JetPay (NASDAQ:JTPY) posted its quarterly earnings results on Thursday. The credit services provider reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.03), Fidelity Earnings reports. The company had revenue of $15.87 million during the quarter, compared to analyst estimates of $19.33 million. JetPay had a negative net margin of 4.54% and a negative return on equity of 305.34%.

Top Biotech Stocks To Invest In 2019: Celyad SA(CYAD)

Advisors’ Opinion:

  • [By Joseph Griffin]

    CELYAD SA/ADR (NASDAQ:CYAD) has received a consensus rating of “Buy” from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $47.50.

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

  • [By Max Byerly]

    Shares of CELYAD SA/ADR (NASDAQ:CYAD) have been assigned a consensus recommendation of “Buy” from the six analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $53.00.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Lisa Levin]

    Breaking news

    Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis, Inc. (NASDAQ: ABAX) for $83 per share in cash.
    Boot Barn Holdings Inc (NYSE: BOOT) reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    CELYAD SA/ADR (NASDAQ: CYAD) reported launch of 1.8 million share offering.
    Verastem Inc (NASDAQ: VSTM) shares dropped 12 percent in pre-market trading after announcing a $35 million common stock offering.

Top Biotech Stocks To Invest In 2019: Home BancShares, Inc.(HOMB)

Advisors’ Opinion:

  • [By Tim Melvin]

    This was especially the case with Home BancShares Inc. (NASDAQ: HOMB), a regional bank based out of Conway, Arkansas.

    On a Friday afternoon back in summer 2016, I was wrapping up my work and heading out for my “ready for the weekend pizza and vino” run when I got an email from Home BancShares chairman John Allison.

  • [By Joseph Griffin]

    Home BancShares (NASDAQ:HOMB) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Home Bancshares (HOMB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Home Bancshares (HOMB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Medical Stocks To Watch For 2019

The cannabis industry is booming, with $6.7 billion in sales in North America for 2016. And sales are only going to increase, with analysts projecting $20 billion in sales by 2020.

That’s nearly a 200% increase in just four years.

That’s why each week, we provide Money Morning readers with the top marijuana stocks to watch.

But before getting into the top cannabis stocks on our watch list, we wanted to make sure our readers were aware of the risks of investing in pot stocks.

The first issue is marijuana is still illegal under federal law.

Even though some states have legalized both recreational and medical marijuana, the federal status of marijuana makes pot stocks speculative investments for now.

Top 5 Medical Stocks To Watch For 2019: Matador Resources Company(MTDR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Matador Resources Co (NYSE:MTDR) – SunTrust Banks increased their Q3 2018 earnings per share estimates for shares of Matador Resources in a report issued on Monday, September 24th. SunTrust Banks analyst N. Dingmann now forecasts that the energy company will post earnings of $0.35 per share for the quarter, up from their previous forecast of $0.34. SunTrust Banks has a “Hold” rating and a $35.00 price target on the stock. SunTrust Banks also issued estimates for Matador Resources’ Q4 2018 earnings at $0.36 EPS, FY2018 earnings at $1.47 EPS, FY2019 earnings at $1.67 EPS and FY2020 earnings at $2.13 EPS.

  • [By Shane Hupp]

    Several institutional investors and hedge funds have recently made changes to their positions in MTDR. Rehmann Capital Advisory Group raised its position in shares of Matador Resources by 1,042.9% in the 4th quarter. Rehmann Capital Advisory Group now owns 1,863 shares of the energy company’s stock valued at $29,000 after purchasing an additional 1,700 shares in the last quarter. Nisa Investment Advisors LLC raised its position in shares of Matador Resources by 64.5% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,550 shares of the energy company’s stock valued at $40,000 after purchasing an additional 1,000 shares in the last quarter. Oregon Public Employees Retirement Fund raised its position in shares of Matador Resources by 1,453.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 634,633 shares of the energy company’s stock valued at $41,000 after purchasing an additional 593,768 shares in the last quarter. NumerixS Investment Technologies Inc raised its position in shares of Matador Resources by 89.4% in the 4th quarter. NumerixS Investment Technologies Inc now owns 8,002 shares of the energy company’s stock valued at $124,000 after purchasing an additional 3,777 shares in the last quarter. Finally, Dupont Capital Management Corp acquired a new position in shares of Matador Resources in the 4th quarter valued at approximately $152,000. 88.12% of the stock is currently owned by institutional investors.

    TRADEMARK VIOLATION NOTICE: “Matador Resources (MTDR) Shares Up 6%” was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright law. The legal version of this article can be read at www.tickerreport.com/banking-finance/4155370/matador-resources-mtdr-shares-up-6.html.

    About Matador Resources (NYSE:MT

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Matador Resources (MTDR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Matador Resources (MTDR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Matador Resources (MTDR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Matador Resources Co (NYSE:MTDR) – Equities researchers at Capital One Financial raised their Q3 2018 EPS estimates for shares of Matador Resources in a research report issued to clients and investors on Tuesday, September 25th. Capital One Financial analyst R. Tullis now anticipates that the energy company will post earnings of $0.36 per share for the quarter, up from their previous estimate of $0.34. Capital One Financial also issued estimates for Matador Resources’ Q4 2018 earnings at $0.33 EPS and FY2018 earnings at $1.45 EPS.

Top 5 Medical Stocks To Watch For 2019: Celyad SA(CYAD)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of CELYAD SA/ADR (NASDAQ:CYAD) have been assigned a consensus recommendation of “Buy” from the six analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $53.00.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Lisa Levin]

    Breaking news

    Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis, Inc. (NASDAQ: ABAX) for $83 per share in cash.
    Boot Barn Holdings Inc (NYSE: BOOT) reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    CELYAD SA/ADR (NASDAQ: CYAD) reported launch of 1.8 million share offering.
    Verastem Inc (NASDAQ: VSTM) shares dropped 12 percent in pre-market trading after announcing a $35 million common stock offering.

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M

Top 5 Medical Stocks To Watch For 2019: Ennis, Inc.(EBF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    WARNING: “LSV Asset Management Decreases Position in Ennis, Inc. (EBF)” was reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at www.tickerreport.com/banking-finance/4159501/lsv-asset-management-decreases-position-in-ennis-inc-ebf.html.

  • [By Logan Wallace]

    These are some of the media stories that may have impacted Accern’s scoring:

    Get Ennis alerts:

    Ennis (EBF) Issues Earnings Results (americanbankingnews.com) Ennis beats by $0.07, beats on revenue (seekingalpha.com) Ennis up 4% post Q1 results (seekingalpha.com) Ennis, Inc. Reports Results for the First Quarter Ended May 31, 2018 (finance.yahoo.com) Ennis: Fiscal 1Q Earnings Snapshot (finance.yahoo.com)

    Shares of Ennis traded down $0.05, hitting $20.20, during trading on Tuesday, according to Marketbeat.com. The company had a trading volume of 117,000 shares, compared to its average volume of 79,358. The firm has a market cap of $489.94 million, a price-to-earnings ratio of 15.66 and a beta of 0.69. Ennis has a fifty-two week low of $17.65 and a fifty-two week high of $21.50. The company has a quick ratio of 4.63, a current ratio of 5.52 and a debt-to-equity ratio of 0.11.

Top 5 Medical Stocks To Watch For 2019: American Airlines Group, Inc.(AAL)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Among the traditional carriers, Alaska Air had a rating of 775, against an average for all traditional carriers of 741. The only other airline that rated above the average was Delta Air Lines Inc. (NYSE: DAL) at 767. Below it, Air Canada posted a 734, American Airlines Group Inc. (NASDAQ: AAL) a 729 and, well down the scale, United Airlines was pegged at 708.

  • [By Adam Levine-Weinberg]

    For more than three years, the Partnership for Open and Fair Skies — an airline industry trade group sponsored by American Airlines (NASDAQ:AAL), Delta Air Lines (NYSE:DAL), and United Continental (NYSE:UAL) — has aggressively lobbied the U.S. government to halt the expansion of fast-growing Gulf airlines Emirates, Etihad Airways, and Qatar Airways.

  • [By Adam Levine-Weinberg]

    American Airlines (NASDAQ:AAL) — the last holdout among the top three global airlines — quickly matched the increases. This virtually guarantees that higher checked baggage fees are here to stay for U.S. air travelers.

Top 5 Medical Stocks To Watch For 2019: VirnetX Holding Corp(VHC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    VirnetX Holding Co. (NYSEAMERICAN:VHC) saw a large decrease in short interest during the month of September. As of September 28th, there was short interest totalling 10,098,752 shares, a decrease of 3.6% from the September 14th total of 10,476,545 shares. Approximately 18.5% of the company’s stock are sold short. Based on an average daily volume of 633,053 shares, the days-to-cover ratio is currently 16.0 days.

  • [By Paul Ausick]

    VirnetX Holding Corp. (NYSEAMERICAN: VHC) announced Friday morning that the U.S. District Court for the Eastern District of Texas has affirmed an April 2018 jury verdict granting the company a $506.2 million award in a patent infringement case against Apple Inc. (NASDAQ: AAPL). The court denied Apple’s request for a new trial in the case, and it also includes supplemental damages, a sunset royalty (paid when infringing products are phased out) and interest and costs.

  • [By Stephan Byrd]

    VHC traded up $0.10 on Tuesday, hitting $4.10. 918,663 shares of the company were exchanged, compared to its average volume of 270,649. VirnetX has a 12 month low of $2.03 and a 12 month high of $8.75.

    ILLEGAL ACTIVITY NOTICE: “Short Interest in VirnetX Holding Co. (VHC) Expands By 1.2%” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at www.tickerreport.com/banking-finance/3346516/short-interest-in-virnetx-holding-co-vhc-expands-by-1-2.html.

    About VirnetX

  • [By Paul Ausick]

    Late Tuesday, a federal court jury in the eastern district of Texas awarded VirnetX Holding Corp. (NYSEAMERICAN: VHC) $502.6 million in a case that VirnetX brought against Apple Inc. (NASDAQ: AAPL) regarding infringement of VirnetX patents and patented technology.

Top Growth Stocks To Invest In 2019

When it comes to investing, including some boring, defensive stocks in your portfolio is a good thing. This is because investors often forget that markets go both up and down. The market is in a positive mood lately, which is exactly why you will want to consider this trio of boring utility stocks. Here’s why American Water Works, Inc. (NYSE:AWK), Duke Energy Corporation (NYSE:DUK), and Dominion Energy, Inc. (NYSE:D) are all defensive stocks you might want to consider adding to your portfolio today.

Solid dividend growth from an unexpected corner of the market

For investors who favor dividend growth, American Water Works is a good name to consider. That’s because it typically gives investors a smooth ride. American Water Works’ beta, a measure of relative volatility, is an ultra-low 0.05. That suggests it’s 95% less volatile than the broader market. It’s easily the most “boring” stock of this trio if you use beta as the yardstick.

The yield is a modest 2.1%, a little higher than the broader market. However, over the past decade, the company has increased its dividend at roughly 10% annually — more than three times the historical growth rate of inflation. Ten percent is the target for the utility going forward, as well. It’s increased its dividend annually for 11 consecutive years, essentially every year since it came public.   

Top Growth Stocks To Invest In 2019: S&P GSCI(GD)

Advisors’ Opinion:

  • [By Lou Whiteman]

    Scale matters in the government IT business, as larger companies are better able to manage the increasingly large and complex systems customers demand, and a broader cost basis helps in putting together low-cost, competitive bids. In recent years, a wave of mergers and acquisitions has left a clear top two in the market. Industry leader Leidos Holdings (NYSE:LDOS) in 2016 bought the IT business of Lockheed Martin, while General Dynamics (NYSE:GD) vaulted to No. 2 earlier this year via its acquisition of CSRA.

  • [By Lou Whiteman]

    General Dynamics (NYSE:GD) stock has had an odd couple of years, gaining more than 17% in 2017 but still lagging most of its defense rivals. Interest in defense stocks, including General Dynamics, has ebbed in recent months, but the company still trades at a discount to some of its chief rivals.

  • [By Rich Smith]

    Five years ago, General Dynamics (NYSE:GD) was struck by disaster.

    Years of acquisitions in the IT space, designed to turn the defense giant best known for its battle tanks and nuclear submarines into a cybersecurity specialist, had failed to produce significant profit growth. Instead, realizing that it had overpaid for its new subsidiaries, General D acknowledged its mistake, took a $2.9 billion charge to earnings, fired its IT division head (or allowed him to retire “to pursue new professional opportunities”), and reported only its second full-year net loss in the last 30 years.

  • [By Joseph Griffin]

    Riverhead Capital Management LLC increased its holdings in shares of General Dynamics (NYSE:GD) by 223.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 12,055 shares of the aerospace company’s stock after purchasing an additional 8,328 shares during the period. Riverhead Capital Management LLC’s holdings in General Dynamics were worth $2,663,000 at the end of the most recent reporting period.

  • [By Lou Whiteman]

    Lockheed Martin (NYSE:LMT) and General Dynamics (NYSE:GD) are two of the most interesting defense companies to watch right now, each with an impressive list of programs benefiting from increased Pentagon spending but each with issues that have caused investor concerns.

Top Growth Stocks To Invest In 2019: WMIH Corp.(WMIH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    WMIH Corp (NASDAQ:WMIH) hit a new 52-week high on Monday . The stock traded as high as $1.63 and last traded at $1.60, with a volume of 238371 shares. The stock had previously closed at $1.58.

  • [By Jon C. Ogg]

    WMIH Corp. (NASDAQ: WMIH) was started with an Outperform rating and assigned a $1.90 price target at Wedbush Securities on Thursday, and note the prior closing price of $1.57. Unfortunately for WMIH, its shares were lower on Friday after a competing call rated the stock with the equivalent of a Sell rating and assigned a mere $1.25 price target. WMIH also has a one-for-12 reverse stock split coming soon.

  • [By Joseph Griffin]

    WMIH Corp (NASDAQ:WMIH) dropped 5.6% on Monday . The company traded as low as $1.50 and last traded at $1.51. Approximately 4,427,897 shares were traded during mid-day trading, a decline of 33% from the average daily volume of 6,647,711 shares. The stock had previously closed at $1.60.

  • [By Max Byerly]

    News stories about WMIH (NASDAQ:WMIH) have trended somewhat positive on Friday, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. WMIH earned a coverage optimism score of 0.15 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 47.1981961674374 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Shane Hupp]

    WMIH (NASDAQ: WMIH) is one of 31 publicly-traded companies in the “Nondepository credit institutions” industry, but how does it contrast to its rivals? We will compare WMIH to related companies based on the strength of its earnings, profitability, dividends, analyst recommendations, institutional ownership, risk and valuation.

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

    Get Innovative Industrial Properties alerts:

    Return on Equity (ROE) under Consideration Innovative Industrial Properties, Inc. (NYSE:IIPR), Neonode Inc … (stocksnewspoint.com) Morning Miraculous Stocks: Taseko Mines Limited (NYSE:TGB), WMIH Corp. (NASDAQ:WMIH), Innovative Industrial … (journalfinance.net) Dazzling Stocks: Innovative Industrial Properties, Inc. (NYSE:IIPR), SORL Auto Parts, Inc. (NASDAQ:SORL), ReWalk … (thestreetpoint.com) Head-To-Head Contrast: Kennedy-Wilson (KW) vs. Innovative Industrial Properties (IIPR) (americanbankingnews.com) Innovative Industrial (IIPR) versus Colliers International Group (CIGI) Financial Contrast (americanbankingnews.com)

    A number of research analysts have weighed in on the company. Zacks Investment Research raised Innovative Industrial Properties from a “sell” rating to a “hold” rating in a report on Friday, March 16th. ValuEngine raised Innovative Industrial Properties from a “hold” rating to a “buy” rating in a report on Wednesday, May 2nd.

Top Growth Stocks To Invest In 2019: Celyad SA(CYAD)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
  • [By Lisa Levin]

    Breaking news

    Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis, Inc. (NASDAQ: ABAX) for $83 per share in cash.
    Boot Barn Holdings Inc (NYSE: BOOT) reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    CELYAD SA/ADR (NASDAQ: CYAD) reported launch of 1.8 million share offering.
    Verastem Inc (NASDAQ: VSTM) shares dropped 12 percent in pre-market trading after announcing a $35 million common stock offering.

Top 5 Stocks To Buy For 2018

MetLife wins epic battle with federal regulators

6 Types of Financial Advisor

So, Why Else Do the Pundits Hate Annuity Commissions?

The IRS and the Treasury Department must issue immediate guidance on 39 areas of the Tax Cuts and Jobs Act to clarify “entity structure, retirement, wealth transfer and a vast number of other tax planning issues,” Annette Nellen, the American Institute of Certified Public Accountants’ Tax Executive Committee chairwoman, urged the IRS and Treasury on Monday.

In her letter to David Kautter, assistant secretary for Treasury’s Tax Policy Department, and William Paul, the IRS’ deputy chief counsel, Kellen said that the two entities must shed light on various areas to help taxpayers and practitioners comply with their 2017 tax obligations.

The IRS did not return a call for comment by press time.

Nellen’s letter highlights three areas of particular concern:

Nellen further explained that under Section 199A(d)(2), Deduction for Qualified Business Income, more guidance is needed on the meaning of specified service trade or business as defined in the section “namely, any trade or business involving the performance of services in the fields of health, law, accounting, actuarial science, performing arts, consulting, athletics, financial services, brokerage services, or any trade or business where the principal asset of such trade or business is the reputation or skill of 1 or more of its employees or owners, or any trade or business which involves the performance of services that consist of investing and investment management, trading, or dealing in securities, partnership interests or commodities.”

Top 5 Stocks To Buy For 2018: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Dan Caplinger]

    For nine months now, investors in NxStage Medical (NASDAQ:NXTM) have looked forward to the future. Having received and accepted a bid from Fresenius Medical Care (NYSE:FMS) last August to purchase the company for $30 per share in cash, NxStage has seen a lot more volatility in its stock than most acquisition targets. With a key deadline approaching within the next three months, it’s hard not to be anxious about whether the deal will actually go through.

Top 5 Stocks To Buy For 2018: Celyad SA(CYAD)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Lisa Levin]

    Breaking news

    Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis, Inc. (NASDAQ: ABAX) for $83 per share in cash.
    Boot Barn Holdings Inc (NYSE: BOOT) reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    CELYAD SA/ADR (NASDAQ: CYAD) reported launch of 1.8 million share offering.
    Verastem Inc (NASDAQ: VSTM) shares dropped 12 percent in pre-market trading after announcing a $35 million common stock offering.

Top 5 Stocks To Buy For 2018: Rite Aid Corporation(RAD)

Advisors’ Opinion:

  • [By ]

    “Alexa, order me my Lipitor” are five words that could prove financially devastating to pharmacies such as Walgreens Boots Alliance (WBA) , CVS Health (CVS) and Rite Aid (RAD) . 

  • [By Chris Lange]

    Rite Aid Corp. (NYSE: RAD) fiscal third-quarter report is scheduled for late on Wednesday. Consensus estimates are calling for a net loss of $0.02 per share and $7.45 billion in revenue. The shares closed trading at $1.97 apiece on Friday. The consensus price target is $2.11, and the 52-week trading range is $1.38 to $8.77.

  • [By Peter Graham]

    Smallcap retail drugstore stock Rite Aid Corporation (NYSE: RAD) reported Q3 2018 earnings after the market closed Wednesday as the Company struggles with falling profitsin its pharmacy business as increases in branded drug prices have slowed while reimbursement pressure for generics has increased.

Top 5 Stocks To Buy For 2018: Core Laboratories N.V.(CLB)

Advisors’ Opinion:

  • [By Taylor Muckerman]

    Muckerman: I can go. That’ll work. One company I’m paying close attention to is Core Labs (NYSE:CLB). They’re based out of the Netherlands, but they have their U.S., maybe global, headquarters in Houston. This is a premier company that’s involved in reservoir description and enhancement services. So, when you’re looking at a well, they can basically recreate the well in their lab and tell you exactly what kind of fluid, what kind of proppants, what kind of chemicals, what kind of pressure. They can tell you exactly how to get the most bang for your buck. It’s not cheap, but it’s worth it in the long run. And this company is just continually buying back shares with their money. They generate tons of free cash flow.

  • [By Matthew DiLallo]

    That trend was one of the central themes on the first-quarter conference call of oil-field technology company Core Labs (NYSE:CLB), where CEO David Demshur provided his take for why things are different in the oil market this time around.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Core Laboratories (CLB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    Shares of oilfield services company Core Laboratories (NYSE:CLB) have pinballed around in the last three years to yield a total return of 0.9% in that span. That’s not exactly the type of consistency investors are after.

  • [By Shane Hupp]

    Mar Vista Investment Partners LLC decreased its holdings in shares of Core Laboratories (NYSE:CLB) by 4.4% during the 1st quarter, HoldingsChannel.com reports. The firm owned 368,372 shares of the oil and gas company’s stock after selling 16,913 shares during the period. Core Laboratories makes up approximately 1.6% of Mar Vista Investment Partners LLC’s investment portfolio, making the stock its 28th largest holding. Mar Vista Investment Partners LLC’s holdings in Core Laboratories were worth $39,865,000 at the end of the most recent quarter.

  • [By ]

    America’s oil renaissance is powered almost exclusively by technology, as companies like Schlumberger (SLB) and Core Labs (CLB) are breathing new life into once forgotten wells. Nucor (NUE) has a similar leadership position in the steel industry thanks to technology, and that company will only benefit more that President Trump’s tariffs put the market on a more level playing field.

Top 5 Stocks To Buy For 2018: Ventas, Inc.(VTR)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    My timing, however, isn’t always so good, and I sometimes get in too early. But owning a great dividend-paying company at a fair price is better than owning a bad company at any price. Which is why I’m happy to have bought U.S. utility giant The Southern Company (NYSE:SO) and healthcare real estate investment trust (REIT) Ventas, Inc. (NYSE:VTR). And I’ll be just as happy if they fall further from here.

  • [By Joseph Griffin]

    Virginia Retirement Systems ET AL boosted its position in Ventas (NYSE:VTR) by 10.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 204,186 shares of the real estate investment trust’s stock after acquiring an additional 19,200 shares during the quarter. Virginia Retirement Systems ET AL owned 0.06% of Ventas worth $10,113,000 as of its most recent filing with the Securities & Exchange Commission.